BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18936467)

  • 1. Interaction between statins and rituximab in non-Hodgkin's lymphoma.
    Rabinowitz I
    J Clin Oncol; 2008 Nov; 26(33):5486; author reply 5486. PubMed ID: 18936467
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.
    Akhtar S; Maghfoor I
    J Clin Oncol; 2005 Sep; 23(25):6261; author reply 6262. PubMed ID: 16135496
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab not affected by statins?
    Pharmacogenomics; 2009 Feb; 10(2):259. PubMed ID: 19207027
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab (Rituxan/MabThera): the first decade (1993-2003).
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):767-79. PubMed ID: 14686699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECOG 4402: randomized phase III-trial comparing two different rituximab dosing regimens for patients with low tumor burden indolent non-Hodgkin's lymphoma.
    Williams ME
    Curr Hematol Rep; 2004 Nov; 3(6):395-6. PubMed ID: 15496271
    [No Abstract]   [Full Text] [Related]  

  • 6. Should rituximab be used prior to autologous stem-cell transplantation for non-Hodgkin's lymphoma?
    Rodriguez J
    Nat Clin Pract Oncol; 2005 Feb; 2(2):74-5. PubMed ID: 16264876
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: moving targets.
    van Oers MH
    Neth J Med; 2009 Sep; 67(8):309-10. PubMed ID: 19767656
    [No Abstract]   [Full Text] [Related]  

  • 8. Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma.
    Barker CA; Yahalom J
    J Clin Oncol; 2010 Aug; 28(24):e426; author reply e427-8. PubMed ID: 20566995
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of rituximab and its clinical use: thought for the best use?
    Cartron G; Blasco H; Paintaud G; Watier H; Le Guellec C
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):43-52. PubMed ID: 17287129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab and statins.
    Carver JR; Johnson T; Schuster SJ
    J Clin Oncol; 2010 Oct; 28(30):e611; author reply e612. PubMed ID: 20805449
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab: converging mechanisms of action in non-Hodgkin's lymphoma?
    Eisenbeis CF; Caligiuri MA; Byrd JC
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5810-2. PubMed ID: 14676100
    [No Abstract]   [Full Text] [Related]  

  • 12. Is statin use really associated with efficacy of rituximab?
    Asai H; Yokoyama M; Terui Y; Ennishi D; Takeuchi K; Hatake K
    J Clin Oncol; 2010 Aug; 28(24):e424-5; author reply e427-8. PubMed ID: 20567023
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical investigations in aggressive non-Hodgkin lymphoma.
    Jonathan F
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
    [No Abstract]   [Full Text] [Related]  

  • 14. GM1 expression of non-Hodgkin's lymphoma determines susceptibility to rituximab treatment.
    Meyer zum Büschenfelde C; Feuerstacke Y; Götze KS; Scholze K; Peschel C
    Cancer Res; 2008 Jul; 68(13):5414-22. PubMed ID: 18593944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rituximab in combination with conventional chemotherapy for the treatment of non-Hodgkin's lymphoma of the head and neck.
    Manolopoulos L; Gomatos IP; Leandros E; Alevizos L; Georgiou N; Giotakis J; Ferekidis E
    In Vivo; 2009; 23(3):475-8. PubMed ID: 19454517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in primary conjunctiva lymphoma.
    Zinzani PL; Alinari L; Stefoni V; Loffredo A; Pichierri P; Polito E
    Leuk Res; 2005 Jan; 29(1):107-8. PubMed ID: 15541482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
    Prodanovic EM; Korman NJ
    J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular rituximab.
    Singh AD; Peereboom DM
    Eye (Lond); 2007 Dec; 21(12):1453-4. PubMed ID: 18159211
    [No Abstract]   [Full Text] [Related]  

  • 19. In focus: ECOG 4402: Rituximab Extended Schedule or Retreatment Trial (RESORT).
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):152. PubMed ID: 16166942
    [No Abstract]   [Full Text] [Related]  

  • 20. Inefficacy of rituximab in a case of low grade non-Hodgkin's lymphoma with cryoglobulinemia.
    Baronciani D; Angelucci E; Gaziev J; Visani G
    Haematologica; 2002 Jul; 87(7):ELT33. PubMed ID: 12091148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.